| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 26278-26290 |
| Journal | Oncotarget |
| Volume | 6 |
| Issue number | 28 |
| DOIs | |
| Publication status | Published - 2015 |
Cite this
}
MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients. / Lenos, K.J.; Goos, J.A.C.M.; Vuist, I.M.; den Uil, S.H.; Delis-van Diemen, P.M.; Belt, E.J.T.; Stockmann, H.B.A.C.; Bril, H.; de Wit, M.; Carvalho, B.; Giblett, S.; Pritchard, C.A.; Meijer, G.A.; van Kooyk, Y.; Fijneman, R.J.A.; van Vliet, S.J.
In: Oncotarget, Vol. 6, No. 28, 2015, p. 26278-26290.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients
AU - Lenos, K.J.
AU - Goos, J.A.C.M.
AU - Vuist, I.M.
AU - den Uil, S.H.
AU - Delis-van Diemen, P.M.
AU - Belt, E.J.T.
AU - Stockmann, H.B.A.C.
AU - Bril, H.
AU - de Wit, M.
AU - Carvalho, B.
AU - Giblett, S.
AU - Pritchard, C.A.
AU - Meijer, G.A.
AU - van Kooyk, Y.
AU - Fijneman, R.J.A.
AU - van Vliet, S.J.
PY - 2015
Y1 - 2015
U2 - 10.18632/oncotarget.4495
DO - 10.18632/oncotarget.4495
M3 - Article
VL - 6
SP - 26278
EP - 26290
JO - Oncotarget
JF - Oncotarget
SN - 1949-2553
IS - 28
ER -